DDetect kidney cancerDetectCancer.org

Hematuria, renal masses and incidental CT findings

Kidney cancer is often found by chance, but blood in urine must not be ignored.

A practical detection guide to hematuria, flank pain, ultrasound, CT renal mass protocols, MRI, biopsy, Bosniak cysts, hereditary syndromes and why average-risk population screening is not routine.

Screening realitySymptoms not to ignoreImmunotherapyVaccines
Educational, not personal medical advice. Visible blood in urine, persistent microscopic hematuria, unexplained flank pain, a renal mass or weight loss deserves a clinician-led workup. Most hematuria is not kidney cancer, but assuming it is benign can miss kidney, bladder or upper-tract urothelial cancer.
No

broad population screening is recommended for average-risk adults.

Hematuria

visible or persistent microscopic blood in urine needs evaluation.

CT/MRI

renal mass protocols define enhancement, stage and surgical planning.

Genes

VHL, Birt-Hogg-Dube, HLRCC and other syndromes change surveillance.

Brief outline

Most kidney cancers are renal cell carcinomas.

Renal cell carcinoma can be clear cell, papillary, chromophobe or rarer subtypes. Some cancers are small incidental renal masses; others present with hematuria, anemia, weight loss or metastatic symptoms.

CT-style kidney mass visual.
CT renal mass imaging is central to characterization.

Detection frame

Detection splits into two pathways: investigating hematuria or symptoms, and managing an incidental renal mass found on ultrasound, CT or MRI done for another reason.

Do not ignore

Hematuria is the headline warning sign.

Visible blood in urineCan come from infection, stones, prostate, bladder cancer, kidney cancer or upper tract tumors. It needs proper assessment.
Flank pain or massThe old triad of hematuria, flank pain and mass is uncommon and often late.
Unexplained anemia or weight lossSystemic symptoms can occur with larger or advanced tumors.
Varicocele or leg swellingRarely, renal vein/IVC involvement can create vascular signs.
Incidental renal massCommon with modern imaging; the challenge is separating benign cysts/angiomyolipoma from cancer.
Metastatic cluesBone pain, cough, neurologic symptoms or abnormal labs may be the first clue in advanced disease.

Risk and genetics

Smoking, obesity, hypertension and inherited syndromes matter.

Common risksSmoking, obesity, hypertension, chronic kidney disease and dialysis/acquired cystic kidney disease raise risk.
Family historyMultiple relatives, young age, bilateral or multifocal tumors should prompt genetic consideration.
VHLVon Hippel-Lindau can cause clear cell RCC and pancreatic/CNS/retinal lesions; surveillance starts early.
Birt-Hogg-DubeFLCN variants can cause kidney tumors, lung cysts/pneumothorax and skin fibrofolliculomas.
HLRCCFH variants can produce aggressive papillary-type RCC; small lesions matter.
Other genesMET, SDH genes, TSC1/2 and BAP1 can be relevant in selected families.

Screening

Average-risk screening is not routine.

Urine dipsticks and ultrasound are not proven population screening tools for average-risk adults. High-risk genetic syndromes are different: they may need scheduled MRI/CT/ultrasound surveillance in specialist programs.

First look

Urinalysis and urine culture

Useful for hematuria workup but cannot rule out kidney cancer.

Common imaging

Ultrasound

Good for cysts and hydronephrosis, less definitive for complex or small solid masses.

Key test

CT renal mass protocol

Assesses enhancement, renal vein/IVC invasion, nodes and metastases.

Alternative

MRI

Helpful for contrast allergy, equivocal CT, venous invasion and hereditary surveillance.

Selective

Renal mass biopsy

Can avoid unnecessary surgery in benign or metastatic/inflammatory mimics.

Caution

Urine cytology

More relevant to urothelial cancer than typical renal cell carcinoma.

Images, labs and tissue

Renal masses are characterized by enhancement and anatomy.

Ultrasound can find cystic versus solid masses. CT or MRI with renal mass protocol defines enhancement, fat, vessels, nodes and metastases. Biopsy is selective: useful when it changes management, but not required for every surgically treated mass.

CT-style kidney mass visual.
CT renal mass imaging is central to characterization.
Renal cancer pathology visual.
Histology confirms subtype when tissue is sampled or removed.
Kidney and nephron anatomy diagram.
Symptoms and imaging findings depend on kidney anatomy and collecting system involvement.

Pros, cons and controversy

Finding small renal masses can help, but can also overtreat.

Many small renal masses grow slowly, especially in older or frail patients. Active surveillance, ablation, partial nephrectomy and radical nephrectomy all have roles. Whole-body MRI may find kidney masses but also benign cysts that trigger follow-up.

Kidney detection trials ImmunotherapyForKidneyCancer.com VaccineForKidneyCancer.com 50Tests.com

Sources and trials

Good starting points.

NCI kidney cancerGeneral kidney cancer information and diagnosis context. NCI kidney treatment PDQRCC types, staging and workup context. ClinicalTrials.gov kidney detectionDetection and imaging trials.